Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 3701-3750 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07010471
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
PHASE3Recruiting
160 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
PHASE2Recruiting
90 participants
Started: Jul 9, 2025 · Completed: Jan 31, 2029
9 conditions1 sponsor13 locations
NCT07011901
Precision Analytic Research Methods in OCD
NARecruiting
100 participants
Started: Jul 9, 2025 · Completed: Mar 31, 2030
1 condition2 sponsors1 location
NCT07025811
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
PHASE4Recruiting
350 participants
Started: Jul 9, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor4 locations
NCT06826768
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
PHASE1Recruiting
60 participants
Started: Jul 9, 2025 · Completed: May 1, 2029
1 condition2 sponsors1 location
NCT07042451
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
NARecruiting
1,410 participants
Started: Jul 9, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06774235
Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression
PHASE3Recruiting
326 participants
Started: Jul 9, 2025 · Completed: Oct 9, 2028
1 condition1 sponsor23 locations
NCT07168707
Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study
NARecruiting
8 participants
Started: Jul 9, 2025 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location
NCT06972056
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
PHASE4Recruiting
1,335 participants
Started: Jul 9, 2025 · Completed: Dec 1, 2029
1 condition4 sponsors7 locations
NCT06912360
Continous Positive Airway Pressure (CPAP) Support for Acute Hypoxemic Respiratory Failure in Burkina Faso
NARecruiting
240 participants
Started: Jul 9, 2025 · Completed: Feb 20, 2026
1 condition2 sponsors4 locations
NCT07032077
A Phase II Clinical Trial on the Safety, Tolerability, and Efficacy of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors.
PHASE2Recruiting
100 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT07055113
Adapting Rehabilitation Delivery for Maximum Impact at Home-2 (ReDI-2)
NARecruiting
270 participants
Started: Jul 9, 2025 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT07042945
MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
PHASE1Recruiting
28 participants
Started: Jul 9, 2025 · Completed: Apr 6, 2026
1 condition1 sponsor2 locations
NCT07047638
A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine
NARecruiting
171 participants
Started: Jul 9, 2025 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT06244472
A New Generation of Magnetoencephalographs for High Speed Functional Brain Imaging
NARecruiting
80 participants
Started: Jul 9, 2025 · Completed: Aug 31, 2027
2 conditions1 sponsor2 locations
NCT06915025
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
PHASE3Recruiting
500 participants
Started: Jul 9, 2025 · Completed: Oct 31, 2032
4 conditions1 sponsor4 locations
NCT06927999
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
PHASE2Recruiting
42 participants
Started: Jul 9, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT07202728
A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)
N/ARecruiting
1,489 participants
Started: Jul 9, 2025 · Completed: Aug 30, 2030
1 condition14 sponsors14 locations
NCT06002763
Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women
N/ARecruiting
200 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06892288
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG
PHASE2/PHASE3Recruiting
50 participants
Started: Jul 9, 2025 · Completed: Aug 31, 2026
2 conditions1 sponsor16 locations
NCT06642220
Ablative Radioembolization of Renal Cell Carcinoma Trial
PHASE2Recruiting
16 participants
Started: Jul 9, 2025 · Completed: Dec 31, 2032
2 conditions2 sponsors1 location
NCT05391672
Augmentation of Partial Anterior Cruciate Ligament Tear: Early Results
NARecruiting
30 participants
Started: Jul 9, 2025 · Completed: Mar 19, 2026
2 conditions1 sponsor1 location
NCT07059624
Femoral Arterial Cannulation in Pediatrics
NARecruiting
80 participants
Started: Jul 9, 2025 · Completed: Jan 1, 2027
3 conditions1 sponsor1 location
NCT06923618
Cancer of the Lung And SeneScencE - Prospective Cohort 1
NARecruiting
385 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2032
1 condition1 sponsor1 location
NCT07043972
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
PHASE2Recruiting
55 participants
Started: Jul 9, 2025 · Completed: Jan 1, 2031
1 condition1 sponsor2 locations
NCT06661564
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pilot Study
NARecruiting
90 participants
Started: Jul 9, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06722521
GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification
PHASE4Recruiting
7,435 participants
Started: Jul 9, 2025 · Completed: Oct 31, 2032
2 conditions1 sponsor1 location
NCT06834633
Nephroprotection in Severe Trauma Patients With Kidney Stress
NARecruiting
523 participants
Started: Jul 9, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor6 locations
NCT06490770
Analysis of the Pathophysiological and Functional State of the Knee Joint
NARecruiting
25 participants
Started: Jul 9, 2025 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT06678841
ELEVATE-HFpEF Clinical Study
NARecruiting
700 participants
Started: Jul 9, 2025 · Completed: Feb 28, 2029
1 condition1 sponsor5 locations
NCT06986421
Perception of Advanced Rehabilitation Technologies Among Post-Stroke Patients and Rehabilitation Staff
N/ARecruiting
80 participants
Started: Jul 8, 2025 · Completed: Jul 8, 2026
1 condition1 sponsor1 location
NCT06885697
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
PHASE1Recruiting
100 participants
Started: Jul 8, 2025 · Completed: Jun 1, 2044
8 conditions1 sponsor1 location
NCT07028515
Self-controlled Practice on Motor Learning and Motivation in Parkinson's Disease
N/ARecruiting
72 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT07070791
Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer
NARecruiting
40 participants
Started: Jul 8, 2025 · Completed: May 1, 2026
4 conditions1 sponsor1 location
NCT06845514
Impact of Resistance Training Intensity on Blood Pressure
NARecruiting
36 participants
Started: Jul 8, 2025 · Completed: Dec 31, 2028
4 conditions1 sponsor1 location
NCT06799234
Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)
PHASE2Recruiting
240 participants
Started: Jul 8, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06692686
AFO Prescription to Optimize Post-Stroke Function
NARecruiting
120 participants
Started: Jul 8, 2025 · Completed: Oct 31, 2027
3 conditions5 sponsors4 locations
NCT06709469
Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults
PHASE1Recruiting
10 participants
Started: Jul 8, 2025 · Completed: Dec 1, 2030
1 condition1 sponsor1 location
NCT05930496
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
NARecruiting
30 participants
Started: Jul 8, 2025 · Completed: Jul 1, 2027
3 conditions2 sponsors1 location
NCT07017023
Combined Blood Pressure Medication and Activity Scheduling for Low Mood
EARLY_PHASE1Recruiting
76 participants
Started: Jul 8, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06893965
Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NARecruiting
100 participants
Started: Jul 8, 2025 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT07059793
MITRIS China Post Market Clinical Follow-up (PMCF) Study
N/ARecruiting
250 participants
Started: Jul 8, 2025 · Completed: Dec 31, 2038
1 condition4 sponsors7 locations
NCT07090889
Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome.
PHASE1Recruiting
64 participants
Started: Jul 8, 2025 · Completed: Feb 11, 2026
1 condition1 sponsor1 location
NCT06950177
Pancoronavirus Vaccine Study in Healthy Adults
PHASE1Recruiting
51 participants
Started: Jul 8, 2025 · Completed: Aug 30, 2026
3 conditions2 sponsors1 location
NCT07019571
tDCS and Urge in BFRBs
NARecruiting
55 participants
Started: Jul 8, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT07030010
Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses
NARecruiting
20 participants
Started: Jul 8, 2025 · Completed: Dec 19, 2025
1 condition1 sponsor1 location
NCT07069309
A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Adults, Including Those at Higher Risk of Severe COVID-19
PHASE3Recruiting
100 participants
Started: Jul 8, 2025 · Completed: Jan 6, 2026
2 conditions2 sponsors6 locations
NCT06970665
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
PHASE4Recruiting
20 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor12 locations
NCT07076407
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
PHASE3Recruiting
450 participants
Started: Jul 8, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor16 locations
NCT07219875
Training Reward Responsiveness Through Virtual Reality
PHASE2Recruiting
80 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location